A research team led by Dr Somnath Mukhopadhyay, Professor Brian Lipworth and Dr Colin Palmer, has found that a specific genetic variant, known as the Arg/Arg-16 variant, causes salmeterol to be ineffective.
Their research shows that while most patients on salmeterol have their asthma well controlled, those with the Arg/Arg-16 variant have almost double the number of asthma attacks compared to those with the other forms of this gene.
Future research will determine if genetic testing for the Arg/Arg 16 variant should be used in deciding routine asthma prescribing. This is a first step in the path to "personalized medicine" where genetic information will lead to the more effective use of drugs.
"It was apparent that some patients with asthma could be failing to respond to inhaled salmeterol, but we have identified a likely cause for this that is linked to this genetic status," said Dr Mukhopadhyay, of the Children’s Asthma and Allergy Research Unit at the University.
"Where this discovery takes us is towards more personalised asthma treatment, where we can identify which medicines can be used or avoided depending on an individual’s genetic profile and we can ensure the best possible treatment."
The Arg/Arg-16 variant genetic status is reasonably common and it is present in around 13% of young people with asthma in Tayside. The Dundee team studied 546 children and adolescents with asthma in Tayside.
The findings follow studies in America where the US Food and Drug Administration, the principal food and drug regulatory organisation in the United States, has previously warned in November 2005 that salmeterol was not effective in certain individuals, especially African Americans, although the genetic status of these individuals was not studied.
Salmeterol is part of a group of drugs known as beta-agonists, and is widely prescribed within the National Health Service to patients with asthma who fail to respond well to inhaled steroids.
There are 5.2 million people in the UK currently receiving various forms of asthma treatment, and an estimated 675,000 within this population carry the Arg/Arg-16 gene variation and therefore may not benefit from salmeterol treatment.
There are other drugs that can be used as alternative treatments in these individuals.
Although genetic testing is not performed through the NHS, it is important to note that the patients who are put on salmeterol should monitor if the medicine is working or not. If asthma is still poorly controlled on salmeterol, then alternatives, rather than additional treatments, may be more useful.
The results are published today by the leading chest medical journal Thorax, published by the British Thoracic Society and the BMJ Publishing Group.
Roddy Isles | alfa
The cytoskeleton of neurons has been found to be involved in Alzheimer's disease
18.01.2019 | University of the Basque Country
Bioinspired nanoscale drug delivery method developed by WSU, PNNL researchers
10.01.2019 | Washington State University
The scientific and political community alike stress the importance of German Antarctic research
Joint Press Release from the BMBF and AWI
The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...
World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles
The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.
Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.
In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...
Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.
It all starts with an ear. Empa researcher Michael Hausmann removes the object shaped like a human ear from the 3D printer and explains:
The phenomenon of so-called superlubricity is known, but so far the explanation at the atomic level has been missing: for example, how does extremely low friction occur in bearings? Researchers from the Fraunhofer Institutes IWM and IWS jointly deciphered a universal mechanism of superlubricity for certain diamond-like carbon layers in combination with organic lubricants. Based on this knowledge, it is now possible to formulate design rules for supra lubricating layer-lubricant combinations. The results are presented in an article in Nature Communications, volume 10.
One of the most important prerequisites for sustainable and environmentally friendly mobility is minimizing friction. Research and industry have been dedicated...
16.01.2019 | Event News
14.01.2019 | Event News
12.12.2018 | Event News
18.01.2019 | Materials Sciences
18.01.2019 | Life Sciences
18.01.2019 | Health and Medicine